Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Medical Journal March 29, 2023

2.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

3.

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

4.

Targeted radiation therapy shows near-complete response in rare sarcoma patients

5.

Ketamine plus psychotherapy for "excellent" PTSD


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot